Labshake search
Citations for TriLink BioTechnologies :
1 - 21 of 21 citations for TET 830 modified since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2024Quote: ... 2’-fluoro modified CTP and 2’-fluoro modified UTP (TriLink Biotechnologies). All RNA aptamers were purified through denaturing polyacrylamide gel electrophoresis (0.75 mm ...
-
bioRxiv - Genomics 2023Quote: ... Modified nucleotides were purchased from Trilink. Recombinant AAV vectors were produced by triple transfection in HEK293 cells as previously described (28) ...
-
bioRxiv - Molecular Biology 2021Quote: ... Modified UTP analogs were purchased from TriLink, Inc.
-
bioRxiv - Molecular Biology 2020Quote: ... All modified NTPs were purchased from TriLink. The sequences included in the short unmodified dataset (UNM-S) ...
-
bioRxiv - Cell Biology 2022Quote: Protected 5’ maleimide-modified oligonucleotides were purchased from Trilink or GeneLink and were deprotected according to manufacturer’s protocol ...
-
bioRxiv - Immunology 2022Quote: ... and chemically modified N1-methylpseudouridine-5’-triphosphate (Trilink BioTechnologies) instead of the normal nucleotide ...
-
bioRxiv - Genomics 2024Quote: ... 1 mM ATP or a modified ATP analog (Trilink, 2’-O-Methyladenosine-5’-Triphosphate ...
-
bioRxiv - Immunology 2022Quote: ... Cas9 mRNA (CleanCap, 5-methoxyuridine-modified) was purchased from TriLink Biotechnologies ...
-
bioRxiv - Bioengineering 2024Quote: HPLC-purified synthetic chemically modified sgRNAs were purchased from TriLink Biotechnologies (San Diego ...
-
bioRxiv - Cell Biology 2020Quote: Chemically modified mRNA encoding ETV2 (modRNA(ETV2)) was generated by TriLink BioTechnologies ...
-
bioRxiv - Immunology 2022Quote: ... Synthetic modified mRNA-LUC (with 5MoU modifications) was purchased from TriLink Technologies.
-
bioRxiv - Immunology 2024Quote: ... Methyl-pseudouridine (SYNTHGENE)-modified mRNAs were capped using Cap1 Analogue Reagent (TriLink) and further purified by Monarch RNA purification columns (NEB ...
-
bioRxiv - Immunology 2024Quote: ... Modified mRNA transcript with full substitution of Pseudo-U was synthesized by TriLink Biotechnologies using proprietary CleanCap® technology ...
-
bioRxiv - Immunology 2023Quote: ... mRNAs were modified with N1-Methyl-pseudouridine (Synthgene) and capped using CleanCap Reagent (TriLink). After this ...
-
bioRxiv - Cancer Biology 2024Quote: ... Modified aptamers that carried both 2’FY and 2’OMeR were purchased from TriLink BioTechnologies (San Diego ...
-
bioRxiv - Immunology 2022Quote: ... the modified mRNA was synthesized by replacing UTP in the kit with pseudo-UTP (TriLink).
-
bioRxiv - Molecular Biology 2023Quote: Reagents to prepare Cap0- and Cap1-modified Renilla Luciferase (RLuc) mRNA using the CleanCap technology (Trilink)were provided as part of a cooperation with Trilink Bioscience ...
-
bioRxiv - Bioengineering 2023Quote: ... and m1Ψ-modified spike mRNA with di-proline substitutions of K968 and V969 were obtained from Trilink biotechnologies (San Diego ...
-
bioRxiv - Cancer Biology 2023Quote: ... the Zbtb46 ORF sequence “ATGAACAACCGAAAGGAAGATATGGAAATCACTTCTCACTACCGGCATCTGCTTC GAGAGCTCAATGAGCAGAGGCAGCACGGAGTCCTCTGTGATGCGTGCGTCGTGG TGGAGGGCAAGGTCTTCAAGGCACATAAGAACGTCTTGCTTGGGAGCAGCCGCTA CTTTAAGACGCTCTACTGCCAGGTACAGAAGACATCTGACCAGGCCACCGTCACT CACTTGGACATTGTTACAGCCCAGGGCTTCAAGGCCATTATTGACTTCATGTACTC CGCCCATCTGGCTCTCACTAGTAGGAATGTCATCGAGGTGATGTCAGCTGCCAGC TTCCTACAGATGACTGACATTGTGCAGGCCTGCCATGATTTCATCAAGGCTGCACT GGACATCAGCATAAAGTCAGATGCCTCCGATGAACTCTCAGAATTTGAGATTGGCA CCCCAGCCAGCAACAGTACAGAGGCGTTGATCTCAGCTGTGATGGCTGGAAGGAG TATCTCCCCATGGTTGGCTCGGAGAACAAGTCCTGCCAATTCTTCTGGAGACTCTG CCATTGCCAGCTGTCATGAAGGAGGAAGCAGCTATGGGAAGGAGGACCAGGAAC CCAAAGCTGATGGCCCTGATGACGTTTCTTCACAGTCTTTGTGGCCTGGAGATGTA GGCTATGGGTCTCTGCGCATCAAGGAAGAACAGATTTCACCATCACATTATGGAGG GAGTGAGCTTCCATCTTCCAAGGACACTGCAATACAGAATTCTTTATCAGAACAGG GTTCTGGGGATGGCTGGCAGCCCACAGGCCGGAGGAAGAATCGGAAAAACAAAG AGACTGTCCGACACATCACCCAGCAGGTGGAGGAGGACAGCCAGGCTGGCTCTC CAGTACCTTCATTCCTACCCACATCGGGATGGCCTTTCAGCAGCCGAGACTCAAAT GTAGACCTGACGGTCACTGAGGCCAGCAGCTTGGACAGCCGAGGCGAGAGAGCA GAGCTCTATGCTCACATCGATGAGGGCCTACTAGGAGGAGAAACCAGCTACTTGG GCCCACCCCTCACCCCAGAGAAGGAAGAAGCACTACACCAGGCTACTGCAGTGG CCAATCTTCGTGCTGCACTCATGAGTAAGAACAGTCTGCTGTCACTCAAGGCTGAC GTGCTCGGTGATGATGGCTCACTTCTGTTCGAGTACCTGCCCAAAGGTGCCCACT CACTGTCTCGTAAGTGCAAGTTCTGGTGTGTCACTGTGTCTTCCTTTGGTTTAAGCA CCTCAGTTCAGCCCTTCAGACCCTGGAGTCACTGA” was made into a modified mRNA transcript with complete substitution of pseudo-U in RNase-free water from TriLink Biotechnologies ...
-
bioRxiv - Bioengineering 2022Quote: ... and 1 µg of chemically modified sgRNA (Synthego, Menlo Park, CA) and 1.5 µg codon optimized BE4 mRNA (TriLink Biotechnologies, San Diego, CA) and placed in the 20µl cuvette provided and CB-150 was the Amaxa protocol used ...
-
bioRxiv - Bioengineering 2020Quote: ... T cells were electroporated with 1 µg of chemically modified sgRNA (Synthego, Menlo Park, CA) and 1.5 µg codon optimized BE4 mRNA (TriLink Biotechnologies, San Diego, CA) codon optimized ABE7.10 mRNA (TriLink Biotechnologies ...